Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Trans R Soc Trop Med Hyg. 2021 Apr 14;115(4):406-410. doi: 10.1093/trstmh/traa145.
Mycetoma is a localized, chronic, granulomatous disease that can be caused by fungi (eumycetoma) or bacteria (actinomycetoma). Of the 70 different causative agents implicated in mycetoma worldwide, Actinomadura madurae is the only one that causes multiple cases on all continents. Recently, new Actinomadura species were described as causative agents of human mycetoma. One of these new causative agents was Actinomadura mexicana, which was identified in Latin America. Here we demonstrate that this causative agent is not confined to Latin America and that it is also a causative agent of actinomycetoma in Sudan. The disease was managed by antibiotic treatment alone and resulted in complete cure after 6 months of treatment, which is quick when compared with actinomycetoma cases caused by other Actinomadura species.
足菌肿是一种局部性、慢性、肉芽肿性疾病,可由真菌(真菌性足菌肿)或细菌(放线菌性足菌肿)引起。在全世界与足菌肿有关的 70 种不同病原体中,仅有马杜拉放线菌在所有大洲都引起多发性病例。最近,新的马杜拉放线菌种被描述为人类足菌肿的病原体。其中一种新的病原体是墨西哥马杜拉放线菌,它在拉丁美洲被发现。在这里,我们证明这种病原体不仅局限于拉丁美洲,而且也是苏丹放线菌性足菌肿的病原体。该病仅通过抗生素治疗进行管理,在治疗 6 个月后完全治愈,与其他马杜拉放线菌引起的放线菌性足菌肿病例相比,这一治疗速度很快。